Emla and Factor viii inhibition - a phase IV clinical study of FDA data
Factor viii inhibition is reported only by a few people who take Emla.
The phase IV clinical study analyzes which people take Emla and have Factor viii inhibition. It is created by eHealthMe based on reports of 4,645 people who have side effects while taking Emla from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,645 people reported to have side effects when taking Emla.
Among them, 2 people (0.04%) have Factor viii inhibition.
What is Emla?
Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 4,653 Emla users for its effectiveness, alternative drugs and more.
What is Factor viii inhibition?
Factor viii inhibition (suppression of factor viii) is found to be associated with 289 drugs and 232 conditions by eHealthMe.
Number of Emla and Factor viii inhibition reports submitted per year:
Gender of people who have Factor viii inhibition when taking Emla *:
- female: 0.0 %
- male: 100 %
Age of people who have Factor viii inhibition when taking Emla *:
- 0-1: 50 %
- 2-9: 50 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Emla *:
- Amoxicillin: 1 person, 50.00%
- Amicar: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Emla and have Factor viii inhibition?Check whether Factor viii inhibition is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Factor viii inhibition and when was it recovered:
Expand to all the drugs that have ingredients of lidocaine; prilocaine:
Alternative drugs to, pros and cons of Emla:
- Emla (4,653 reports)
Common Emla side effects:
- Fatigue (feeling of tiredness): 477 reports
- Diarrhea: 343 reports
- Nausea and vomiting: 297 reports
- Fever: 287 reports
- Headache (pain in head): 283 reports
- Weakness: 281 reports
- Rashes (redness): 247 reports
- Breathing difficulty: 244 reports
Browse all side effects of Emla:a b c d e f g h i j k l m n o p q r s t u v w x y z
Factor viii inhibition treatments and more:
- Factor viii inhibition (1,182 reports)
COVID vaccines that are related to Factor viii inhibition:
- Factor viii inhibition in Moderna COVID Vaccine
- Factor viii inhibition in Pfizer BioNTech Covid Vaccine
- Factor viii inhibition in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Factor viii inhibition:
- Factor viii inhibition (289 drugs)
All the conditions that are associated with Factor viii inhibition:
- Factor viii inhibition (232 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Artane and Type 1 Diabetes - a second ago
- Acyclovir and Mitral Valve Prolapse - 3 seconds ago
- Naftin and Irritability - 12 seconds ago
- Ceftin and Humira drug interaction - 12 seconds ago
- Skyla and Stress And Anxiety - 15 seconds ago
- Flovent and Zantac drug interaction - 16 seconds ago
- Alcohol and Megacolon - 19 seconds ago
- Amphetamine Salt Combo and Viibryd drug interaction - 20 seconds ago
- Praluent and Amlodipine drug interaction - 23 seconds ago
- Excedrin and Rhabdomyolysis - 23 seconds ago